• NEWS
    • Australian Shares
    • US Shares
    • World Economy
  • ASX Companies
    • Consumer
    • Energy
    • Financial
    • Food & Beverages
    • Healthcare
    • Industrial
    • Infrastructure
    • Media
    • Mining
    • Oil & Gas
    • Retail
    • Technology
    • Telecommunication
  • Market
    • Commodities
    • Currency
    • IPO
    • Hybrid Security
    • Market Updates
    • Upcoming Dividends
    • Dividend Yield
    • Director’s Interests
  • Editorial
  • Videos
  • Investor Education
  • Life & Luxury
    • Food & Drinks
    • Travel
    • Gadgets
    • Health & Wellness
    • Lifestyle
  • Forum
  • Need Recommendations?
Search
Sunday, December 8, 2019
  • Home
  • About
  • Meet The Team
  • Investment Reports
  • Contact Us
  • Advertise With us
Kalkine Media
  • NEWS
    • Australian Shares
    • US Shares
    • World Economy
  • ASX Companies
    • Consumer
    • Energy
    • Financial
    • Food & Beverages
    • Healthcare
    • Industrial
    • Infrastructure
    • Media
    • Mining
    • Oil & Gas
    • Retail
    • Technology
    • Telecommunication
  • Market
    • Commodities
    • Currency
    • IPO
    • Hybrid Security
    • Market Updates
    • Upcoming Dividends
    • Dividend Yield
    • Director’s Interests
  • Editorial
  • Videos
  • Investor Education
  • Life & Luxury
    • Food & Drinks
    • Travel
    • Gadgets
    • Health & Wellness
    • Lifestyle
  • Forum
  • Need Recommendations?

Recce Pharmaceuticals Ltd. (ASX:RCE)
Share Price and News


Company Profile:

Recce Pharmaceuticals Ltd (ASX: RCE) is an Australia-based biotech company which is pioneering the development along with the commercialisation of a new kind of synthetic antibiotics. RECCE 327, Recce’s patented product, has been developed for the treatment of sepsis and blood infections. It was founded in 2007 and has a manufacturing facility in Australia.



Code : ASX:RCE Healthcare Company


Latest News

Team KalkineFlash News
China To Roll-Off Tariff On Some Soybean and Pork Imports
Team KalkineBlog
ASX Dividend Stars – ALU, SXL, WHC, HVN, SKI
Hina ChowdharyBlog
Stimulating Economic Growth: A Key Challenge for Australian and Global Economies
Team KalkineBlog
A look at a few Outperforming Stocks
Kunal SawhneyBlog
Hydrogen Gas- An Intriguing Oil-Demand Driven Investment Case

Recce Pharmaceuticals Ltd. (ASX:RCE) Latest News


Blog
Health Talk: IBX, CYC, VLS, RCE, VHT, NXS
NEWS
Recce Pharmaceuticals Reports Patent For Its Antibiotics
NEWS
Recce’s Shares Plunged By Over 8% Following The A$1.8 Million Placement Update
Healthcare Companies
Recce Pharmaceuticals Ltd (ASX: RCE)
×

NEED STOCK RECOMMENDATIONS FROM EXPERTS? GET A CALL BACK NOW


By clicking on Submit, you agree to our Privacy Policy. Your information is not shared with third parties.

We provide you with the latest news and videos straight from the stock market. Reach us at: Suite 202, 234 George Street, Sydney NSW 2000

Contact us: info@kalkinemedia.com

  • News
  • Blog
  • Forum
  • Video
  • Editorial
  • Currency
  • Commodity
  • Market Updates
  • Hybrid Security
  • Upcoming Dividend
  • Investor Education
  • CEO Interview
  • Australian Shares
  • Mining
  • Consumer
  • Financial
  • Healthcare
  • Industrial
  • Media
  • Oil & Gas
  • Technology
  • Infrastructure
  • Food & Beverages
  • Telecommunication
  • IPO
  • Retail
  • Cannabis
  • Biotech
  • Metals
  • Resources
  • Dividend Yield
  • US Shares
  • ASX Companies
  • Sponsored
  • Meet The Team
  • Investment Reports

© Kalkine Media Pty Ltd 2019 All Rights reserved
 ACN: 629 651 672     ABN: 84 629 651 672

  • Media
  • Privacy Policy
  • Web Content Policy
  • Terms and Conditions
  • Disclaimer
  • Contact Us

© Kalkine Media Pty Ltd 2018 All Rights reserved
 ACN: 629 651 672     ABN: 84 629 651 672

Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.